ASPERCREME- lidocaine patch 
Lead Chemical Co. Ltd.

----------

Aspercreme Lidocaine Patch

Active ingredient – Lidocaine Patch US 1ct

Lidocaine 4%

Purpose – Lidocaine Patch US 1ct

Topical anesthetic

Use – Lidocaine Patch US 1ct

for the temporary relief of pain

Warnings – Lidocaine Patch US 1ct

For external use only

Do not use – Lidocaine Patch US 1ct

on wounds or on irritated or damage skin
more than 1 patch on your body at a time or with other topical analgesics at the same time
with a heating pad

When using this product – Lidocaine Patch US 1ct

use only as directed
do not bandage tightly
avoid contact with the eyes and mucous membranes
do not expose the area to local heat or to direct sunlight

Stop use and ask a doctor if – Lidocaine Patch US 1ct

condition worsens or symptoms persist for more than 7 days
symptoms clear up and occur again within a few days
redness is present or excessive skin irritation occurs
you experience severe burning pain, swelling, or blistering where the product was applied

If pregnant or breast-feeding, – Lidocaine Patch US 1ct

ask a health professional before use.

Keep out of reach of children and pets. – Lidocaine Patch US 1ct

Used patches may still contain the drug product that can produce serious adverse effects if ingested by children or pets. If swallowed, get medical help or contact a Poison Control Center right away.

Directions – Lidocaine Patch US 1ct

•   adults and children 12 years of age and older:

clean and dry affected area
remove backing from patch by firmly grasping both ends and gently pulling until backing separates in middle
carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area
once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected area
apply to the affected area not more than 3 to 4 times daily
wash hands after applying or removing patch. Throw away the patch after folding sticky ends together.

•   children under 12 years of age: ask a doctor

Inactive ingredients – Lidocaine Patch US 1ct

aluminum glycinate, aluminum hydroxide, cellulose gum, glycerin, methyl acrylate/2-ethylhexyl acrylate copolymer, methylparaben, nonoxynol-30, polyacrylic acid, polysorbate 80, propylene glycol, silica, sodium polyacrylate, tartaric acid, titanium dioxide, urea, water

Active ingredient – Lidocaine Patch Singles US 1ct

Lidocaine 4%

Purpose – Lidocaine Patch Singles US 1ct

Topical anesthetic

Use – Lidocaine Patch Singles US 1ct

For the temporarily relief of pain

Warnings – Lidocaine Patch Singles US 1ct

For external use only

Do not use – Lidocaine Patch Singles US 1ct

on puncture wounds, cuts, irritated or swollen skin
more than 1 patch on your body at a time or with other topical analgesics at the same time
with a heating pad or apply local heat to the area of use

When using this product – Lidocaine Patch Singles US 1ct

use only as directed
do not bandage tightly
avoid contact with the eyes
dispose of used patch in manner that always keeps product away from children or pets. Used patches still contain the drug product that can produce serious adverse effects if a child or pet chews or ingests this patch.

Stop use and ask a doctor if – Lidocaine Patch Singles US 1ct

condition worsens or symptoms persist for more than 7 days
symptoms clear up and occur again within a few days
redness or irritation develops
you experience signs of skin injury, such as pain, swelling, or blistering where the product was applied

If pregnant or breast feeding, – Lidocaine Patch Singles US 1ct

ask a health professional before use.

Keep out of reach of children and pets. – Lidocaine Patch Singles US 1ct

If swallowed, get medical help or contact a Poison Control Center right away.

Directions – Lidocaine Patch Singles US 1ct

adults and children over 12 years of age and older:

clean and dry affected area
remove backing from patch by firmly grasping both ends and gently pulling until backing separates in middle
carefully remove smaller portion of backing from patch and apply exposed portion of patch to affected area
once exposed portion of patch is positioned, carefully remove remaining backing to completely apply patch to affected area
use 1 patch at a time and not more than 3 to 4 times daily

children under 12 years of age: consult a doctor

Inactive ingredients – Lidocaine Patch Singles US 1ct

aluminum glycinate, aluminum hydroxide, cellulose gum, glycerin, methyl acrylate/2-ethylhexyl acrylate copolymer, methylparaben, nonoxynol-30, polyacrylic acid, polysorbate 80, propylene glycol, silica, sodium polyacrylate, tartaric acid, titanium dioxide, urea, water

Package/Label Principal Display Panel – Lidocaine Patch US 1ct

MAX STRENGTH

Aspercreme®with 4% LIDOCAINE
PAIN RELIEF PATCH

NUMBS AWAY PAINFAST ACTING
TARGETS NERVES
FLEXIBLE FABRIC
#1 LIDOCAINE BRAND*

PATCH

FRAGRANCE-FREE
Contains 1 Patch 3-15/16” x 5-1/2” (10 cm x 14 cm)
Pain Relieving Ointment on a Breathable Adhesive Pad

*Among OTC topical analgesics.


Dist. by Chattem, Inc., a Sanofi Company
P.O. Box 2219, Chattanooga, TN
37409-0219 USA
©2022
www.aspercreme.com     Made in Japan

image-01

Label

Package/Label Principal Display Panel – Lidocaine Patch Singles US 1ct

MAX STRENGTH

Aspercreme®with 4% LIDOCAINE
PAIN RELIEF PATCH

NUMBS AWAY PAINFAST ACTING
TARGETS NERVES
FLEXIBLE FABRIC
#1 LIDOCAINE BRAND*

PATCH

FRAGRANCE-FREE
Contains 1 Patch 3-15/16” x 5-1/2” (10 cm x 14 cm)
Pain Relieving Ointment on a Breathable Adhesive Pad

*Among OTC topical analgesics


CHATTEM®
A SANOFI COMPANY
Dist. by Chattem, Inc., a Sanofi Company
P.O. Box 2219, Chattanooga, TN
37409-0219 USA ©2020
www.aspercreme.com
Made in Japan

image-02

Label

ASPERCREME 
lidocaine patch
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:62168-0584
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE246 mg
Inactive Ingredients
Ingredient NameStrength
DIHYDROXYALUMINUM AMINOACETATE ANHYDROUS (UNII: 1K713C615K)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED FORM (UNII: K679OBS311)  
GLYCERIN (UNII: PDC6A3C0OX)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
NONOXYNOL-30 (UNII: JJX07DG188)  
POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
TARTARIC ACID (UNII: W4888I119H)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
UREA (UNII: 8W8T17847W)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:62168-0584-4400 in 1 CARTON05/17/202103/31/2025
11 in 1 POUCH; Type 0: Not a Combination Product
2NDC:62168-0584-5400 in 1 CARTON02/02/2022
21 in 1 POUCH; Type 0: Not a Combination Product
3NDC:62168-0584-6400 in 1 CARTON07/15/2023
31 in 1 POUCH; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph Drug505G(a)(3)02/16/2016
Labeler - Lead Chemical Co. Ltd. (693727091)

Revised: 1/2024
Document Id: 78eddb4d-bd6c-4f22-83fa-a7d68949e1a8
Set id: 275e1343-deef-424a-a883-5e780083af91
Version: 8
Effective Time: 20240125
 
Lead Chemical Co. Ltd.